Despite the precipitous drop in the price of DNA sequencing, global credit crunches have tightened the science budgets able to properly take advantage of the potential of genomics. While this plummet in cost has led to an explosion of “mega-sequencing” projects carried out by large international consortia, it has also democratized and empowered what can be done outside traditional academia and research funding environments.